William Blair Investment Management
LGND icon

William Blair Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

William Blair Investment Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-205,689
Closed -$20.6M – 448
2024
Q3 		$20.6M Buy
205,689
+2,847
+1% +$287K 0.05% 301
2024
Q2 		$17.1M Buy
202,842
+13,595
+7% +$1.08M 0.04% 309
2024
Q1 		$13.8M Buy
189,247
+1,905
+1% +$140K 0.04% 316
2023
Q4 		$13.4M Buy
187,342
+27,549
+17% +$1.63M 0.04% 312
2023
Q3 		$9.57M Buy
159,793
+4,887
+3% +$322K 0.03% 317
2023
Q2 		$11.2M Buy
154,906
+2,152
+1% +$161K 0.04% 320
2023
Q1 		$11.2M Buy
152,754
+11,626
+8% +$826K 0.04% 310
2022
Q4 		$9.43M Sell
141,128
-527,443
-79% -$34.3M 0.04% 316
2022
Q3 		$35.9M Buy
668,571
+33,712
+5% +$1.98M 0.14% 150
2022
Q2 		$35.3M Sell
634,859
-830,442
-57% -$47.1M 0.13% 181
2022
Q1 		$103M Sell
1,465,301
-779,446
-35% -$56.6M 0.31% 105
2021
Q4 		$216M Buy
2,244,747
+39,114
+2% +$3.61M 0.58% 55
2021
Q3 		$192M Buy
2,205,633
+207,570
+10% +$16.1M 0.54% 62
2021
Q2 		$164M Sell
1,998,063
-71,817
-3% -$5.97M 0.51% 79
2021
Q1 		$197M Sell
2,069,880
-1,201,915
-37% -$114M 0.64% 63
2020
Q4 		$203M Buy
3,271,795
+233,510
+8% +$13.3M 0.68% 54
2020
Q3 		$181M Buy
3,038,285
+655,419
+28% +$44.7M 0.7% 47
2020
Q2 		$166M Sell
2,382,866
-54,168
-2% -$3.43M 0.68% 53
2020
Q1 		$111M Buy
2,437,034
+165,823
+7% +$9.4M 0.54% 59
2019
Q4 		$148M Buy
2,271,211
+129,374
+6% +$8.65M 0.59% 54
2019
Q3 		$133M Buy
2,141,837
+703,353
+49% +$44.2M 0.57% 58
2019
Q2 		$102M Buy
1,438,484
+15,594
+1% +$1.15M 0.43% 80
2019
Q1 		$112M Sell
1,422,890
-143,696
-9% -$10.9M 0.47% 66
2018
Q4 		$133M Sell
1,566,586
-84,785
-5% -$9.04M 0.66% 46
2018
Q3 		$283M Sell
1,651,371
-171,258
-9% -$25.8M 0.98% 18
2018
Q2 		$236M Buy
1,822,629
+172,964
+10% +$19.3M 0.88% 18
2018
Q1 		$170M Sell
1,649,665
-338,169
-17% -$33.4M 0.65% 41
2017
Q4 		$170M Buy
1,987,834
+148,590
+8% +$12.9M 0.66% 38
2017
Q3 		$156M Sell
1,839,244
-1,003,571
-35% -$79.5M 0.56% 51
2017
Q2 		$215M Buy
2,842,815
+72,546
+3% +$5.07M 0.78% 39
2017
Q1 		$183M Buy
2,770,269
+823,190
+42% +$54.2M 0.69% 46
2016
Q4 		$123M Buy
1,947,079
+371,477
+24% +$23.4M 0.49% 70
2016
Q3 		$100M Sell
1,575,602
-436,607
-22% -$32.1M 0.38% 84
2016
Q2 		$150M Buy
2,012,209
+41,397
+2% +$3.07M 0.59% 61
2016
Q1 		$132M Buy
1,970,812
+142,573
+8% +$8.67M 0.52% 71
2015
Q4 		$124M Sell
1,828,239
-339,956
-16% -$21M 0.5% 71
2015
Q3 		$116M Buy
+2,168,195
New +$132M 0.24% 129

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair Investment Management's LGND Position: Q4 2024 in Review

William Blair Investment Management sold out of Ligand Pharmaceuticals (LGND) in Q4 2024, closing a stake of 205,689 shares — an estimated $20.6M sold.

William Blair Investment Management first reported a position in LGND in Q3 2015 and held it in 37 quarters. The position peaked at $283M in Q3 2018. 258 funds tracked by Wall St. Rank hold LGND as of Q4 2024.

  • William Blair Investment Management reported no remaining Ligand Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • William Blair Investment Management sold 205,689 Ligand Pharmaceuticals shares in Q4 2024, an estimated $20.6M.
  • William Blair Investment Management first reported a position in Ligand Pharmaceuticals in Q3 2015 and held it in 37 quarters.
  • William Blair Investment Management's Ligand Pharmaceuticals position peaked at $283M in Q3 2018.
  • 258 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2024.

Based on William Blair Investment Management's 13F filing for Q4 2024, filed 10 Feb 2025.